Recently, Particle Cloud, a 3D printing regenerative artificial bone industrialization project, has completed its B+ round of financing, jointly invested by Shaanxi Tianhong Venture Capital Partnership (Limited Partnership), Capitech Venture Capital Co., Ltd., and Beijing ZhengXin Investment Co., LTD.
Particle Cloud, established in 2014, is a national high-tech enterprise that provides advanced materials, innovative products, and intelligent equipment for fields such as bioengineering, healthcare, and advanced manufacturing.
In 2018, Particle Cloud completed the world's first clinical transplantation for the regeneration and repair of large segmental bone defects, and was recognized as one of the top 10 institutions producing core patents in the global engineering frontier of "3D printed bio-tissue regeneration technology." In addition, Particle Cloud served as a drafting unit of the group standardization technical committee of the 3D Printing Medical Device Professional Committee of the China Medical Device Industry Association, participating in the formulation of group standards for additive manufacturing medical devices.
Currently, Particle Cloud has completed the layout of new bioceramic material development, 3D printing product research and development, software design, preclinical studies, implant experiments, surface activity, and functionalization.
At the solution level, the company offers a "customized on demand" series of 3D printers, providing customers with a full set of solutions from 3D printing materials, printing equipment to practical applications.
Taking the application of porous bioceramic artificial bone based on direct writing printing as an example, Particle Cloud selected bioceramic materials with a chemical composition similar to the inorganic components of bone tissue and excellent bioactivity. Using Filament-Free Printing (FFP) technology, ceramic materials are directly printed point by point and layer by layer. Based on parameters such as the size, shape, and internal porosity of bone defects in orthopedic clinical patients, biodegradable artificial bones with precisely customized physicochemical properties and biomimetic structural appearance are produced.